Ever Supreme Bio Technology Co., Ltd

TPEX:6712 Stok Raporu

Piyasa değeri: NT$15.0b

Ever Supreme Bio Technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Ever Supreme Bio Technology has been growing earnings at an average annual rate of 58.6%, while the Biotechs industry saw earnings growing at 19.2% annually. Revenues have been growing at an average rate of 51.5% per year. Ever Supreme Bio Technology's return on equity is 33.1%, and it has net margins of 62%.

Anahtar bilgiler

58.6%

Kazanç büyüme oranı

58.7%

EPS büyüme oranı

Biotechs Sektör Büyümesi12.2%
Gelir büyüme oranı51.5%
Özkaynak getirisi33.1%
Net Marj62.0%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

Mar 11
Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

Jan 13
We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Nov 17
If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Gelir ve Gider Dağılımı

Ever Supreme Bio Technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TPEX:6712 Gelir, gider ve kazançlar (TWD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2482451149103
31 Mar 2480544649101
31 Dec 237585394899
30 Sep 236835714595
30 Jun 236283354195
31 Mar 236213264090
31 Dec 226282014091
30 Sep 226031534597
30 Jun 225753484585
31 Mar 225133744387
31 Dec 214393704584
30 Sep 213102613979
30 Jun 21193153690
31 Mar 21112-9435100
31 Dec 2071-10730109
30 Sep 2053-11842119
30 Jun 2028-12443110
31 Mar 2019-10243100
31 Dec 1911-944395
30 Sep 192-803089
30 Jun 190-852992
31 Mar 190-772583
31 Dec 180-692173
30 Sep 180-561760
30 Jun 180-431346
31 Mar 180-371238
31 Dec 170-311129

Kaliteli Kazançlar: 6712 has a large one-off gain of NT$170.3M impacting its last 12 months of financial results to 30th June, 2024.

Büyüyen Kar Marjı: 6712's current net profit margins (62%) are higher than last year (53.3%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 6712 has become profitable over the past 5 years, growing earnings by 58.6% per year.

Büyüme Hızlandırma: 6712's earnings growth over the past year (52.5%) is below its 5-year average (58.6% per year).

Kazançlar vs. Sektör: 6712 earnings growth over the past year (52.5%) exceeded the Biotechs industry 33.2%.


Özkaynak Getirisi

Yüksek ROE: 6712's Return on Equity (33.1%) is considered high.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin